Scotts Miracle-Gro (SMG) recently spotlighted growth initiatives, margin progress, and balance sheet repair in its Q2 update, with management describing fiscal 2026 as a turning point for the business.

The recent Q2 update and upcoming appearance at the William Blair Growth Stock Conference come after a period where the stock’s 90 day share price return declined 16.43%, contributing to a 5 year total shareholder return that is down 68.24%. The 1 year total shareholder return is broadly flat, suggesting long term sentiment has been weak even as investors reassess near term prospects.

If you are weighing SMG’s reset against other opportunities in the market, it can be useful to see what investors are watching in fast growing themes such as 20 top founder-led companies

With the stock down sharply over five years but trading at a discount to analyst targets and some intrinsic value estimates, you have to ask: Is Scotts Miracle-Gro undervalued today, or is it already pricing in a 2026 reset?

Most Popular Narrative: 34.1% Overvalued

Scotts Miracle-Gro’s most followed narrative pegs fair value at $43.49, well below the last close at $58.34, which suggests the stock trades above that reference point.

This isn’t a hypergrowth story. It’s a durability story. As food security, indoor agriculture, and yield efficiency gain importance globally, companies with cultivation expertise stand to benefit quietly rather than explosively.

Curious how a durability story still ends up with a lower fair value than today’s price? The narrative leans heavily on measured revenue growth, rebuilding margins, and a profit multiple that assumes cultivation expertise earns only a modest premium. The tension between brand strength and slower growth expectations sits at the heart of this valuation.

Result: Fair Value of $43.49 (OVERVALUED)

However, this durability story could be challenged if cannabis cultivation remains pressured or if margin repair stalls, leaving the stock exposed to further sentiment setbacks.

Another View: Cash Flows Point the Other Way

While the popular narrative sees fair value at $43.49 and labels Scotts Miracle-Gro overvalued, the SWS DCF model tells a different story. In this view, the stock at $58.34 sits about 22.4% below an estimated fair value of $75.17, raising the question of which lens investors should trust.

Next Steps

Looking for more investment ideas?

If SMG is only one piece of your watchlist, now is the time to broaden your options with focused stock ideas built from clear fundamentals and risk profiles.

• Target value opportunities that combine quality and attractive pricing by reviewing 51 high quality undervalued stocks.
• Prioritise resilience and capital preservation with the 67 resilient stocks with low risk scores.
• Spot earlier stage opportunities with solid financials through the 27 elite penny stocks with strong financials.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.